Press release
Congestive Heart Failure Market Size in the 7MM was ~USD 6 Billion in 2022 | DelveInsight
Congestive Heart Failure Market
Key Takeaways from the Congestive Heart Failure Market Research Report
• The increase in Congestive Heart Failure Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
• As per DelveInsight analysis, the Congestive Heart Failure Market is anticipated to witness growth at a considerable CAGR.
• The leading Congestive Heart Failure Companies working in the market include Novartis, Boehringer Ingelheim, Eli Lilly, Bayer, Merck, AstraZeneca, Amgen, Otsuka Pharmaceutical, Cytokinetics, Mesoblast, Novo Nordisk, Lexicon Pharmaceuticals, scPharmaceuticals, Bristol-Myers Squibb, Intra-Cellular Therapies, Tenax Therapeutics, BioCardia, and others.
• Promising Congestive Heart Failure Pipeline Therapies in the various stages of development include Lixivaptan, KW-3902IV, Irbesartan, rolofyline, and others.
• April 2024:- Boehringer Ingelheim- Post Marketing Surveillance on Long Term Drug Use of JARDIANCE® Tablets in Patients With Chronic Heart Failure in Japan. Study objective is to investigate the safety and effectiveness of long-term daily use of JARDIANCE® Tablets in patients with chronic heart failure (CHF) under real-world use.
• March 2024:- Nihon Kohden- Track changes in non-invasive central venous pressure across hospital stay and relationship with readmission. Determining the degree of congestion is important in deciding appropriate timing for discharging hospitalized heart failure patients. Central venous pressure (CVP) reflects the returning blood volume to the heart and can guide therapy to relieve congestion. However, the conventional method used to measure CVP has notable limitations as it is an invasive procedure that requires placement of a central venous catheter.
Discover which therapies are expected to grab the Congestive Heart Failure Market Share @ Congestive Heart Failure Market Outlook- https://www.delveinsight.com/sample-request/congestive-heart-failure-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Congestive Heart Failure Overview
Congestive Heart Failure (CHF) is a chronic medical condition where the heart is unable to pump blood efficiently enough to meet the body's needs. It typically occurs when the heart muscle becomes weakened or damaged, leading to a decrease in its ability to contract effectively or to relax properly between beats. As a result, blood flow out of the heart is reduced, causing blood to back up into the veins leading to the heart and causing congestion in various parts of the body.
Congestive Heart Failure Epidemiology Insights
The epidemiology section of Congestive Heart Failure offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.
Download the report to understand which factors are driving Congestive Heart Failure Epidemiology trends @ Congestive Heart Failure Epidemiological Insights- https://www.delveinsight.com/sample-request/congestive-heart-failure-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Congestive Heart Failure Drugs Market
The Congestive Heart Failure Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Congestive Heart Failure signaling in Congestive Heart Failure are likely to uncover new therapeutic targets and further expand treatment options for patients.
Congestive Heart Failure Treatment Market Landscape
The Congestive Heart Failure treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Congestive Heart Failure has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.
To know more about Congestive Heart Failure treatment guidelines, visit @ Congestive Heart Failure Treatment Market Landscape- https://www.delveinsight.com/sample-request/congestive-heart-failure-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Congestive Heart Failure Market Outlook
The report's outlook on the Congestive Heart Failure market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Congestive Heart Failure therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Congestive Heart Failure drug and late-stage pipeline therapy. It assesses their impact based on various factors such as annual therapy costs, inclusion/exclusion criteria, mechanism of action, compliance rates, market demand, patient population growth, covered patient segments, anticipated launch year, competition with other therapies, brand value, and input from key opinion leaders. The analyzed Congestive Heart Failure market data are presented concisely through relevant tables and graphs to offer a clear overview of the market dynamics.
Congestive Heart Failure Drugs Uptake
The drug chapter of the Congestive Heart Failure report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to Congestive Heart Failure.
Major Congestive Heart Failure Companies
Several Congestive Heart Failure Companies working in the market include Novartis, Boehringer Ingelheim, Eli Lilly, Bayer, Merck, AstraZeneca, Amgen, Otsuka Pharmaceutical, Cytokinetics, Mesoblast, Novo Nordisk, Lexicon Pharmaceuticals, scPharmaceuticals, Bristol-Myers Squibb, Intra-Cellular Therapies, Tenax Therapeutics, BioCardia, and others
Learn more about the FDA-approved drugs for Congestive Heart Failure @ Drugs for Congestive Heart Failure Treatment- https://www.delveinsight.com/sample-request/congestive-heart-failure-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Congestive Heart Failure Market Research Report
• Coverage- 7MM
• Congestive Heart Failure Companies- Novartis, Boehringer Ingelheim, Eli Lilly, Bayer, Merck, AstraZeneca, Amgen, Otsuka Pharmaceutical, Cytokinetics, Mesoblast, Novo Nordisk, Lexicon Pharmaceuticals, scPharmaceuticals, Bristol-Myers Squibb, Intra-Cellular Therapies, Tenax Therapeutics, BioCardia, and others
• Congestive Heart Failure Pipeline Therapies- Lixivaptan, KW-3902IV, Irbesartan, rolofyline, and others.
• Congestive Heart Failure Market Dynamics: Congestive Heart Failure Market Drivers and Barriers
• Congestive Heart Failure Market Access and Reimbursement, Unmet Needs and Future Perspectives
Discover more about Congestive Heart Failure Drugs in development @ Congestive Heart Failure Clinical Trials Assessment- https://www.delveinsight.com/sample-request/congestive-heart-failure-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Key Insights
2. Report Introduction
3. Executive Summary
4. Key Events
5. SWOT Analysis
6. Congestive Heart Failure (CHF) Market Overview at a Glance
7. Disease Background and Overview
8. Treatment
9. Heart Failure with Preserved Ejection Fraction: Diagnosis and Management (2017)
10. ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure (2021)
11. JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure (Update From 2017)
12. American College of Cardiology (ACC), American Heart Association (AHA), and HF Society of America (HFSA) (2021)
13. Chronic Heart Failure in Adults: Diagnosis and Management (NICE Guidelines 2018)
14. Acute Heart Failure: Diagnosis and Management (NICE Guidelines 2014)
15. Epidemiology and Patient Population
16. Country Wise-Epidemiology of HF
18. Patient Journey
19. Marketed Drugs
20. Emerging Drugs
21. Congestive Heart Failure (CHF): Seven Major Market Analysis
22. Unmet Needs
23. Market Access and Reimbursement
24. Appendix
25. DelveInsight Capabilities
26. Disclaimer
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: +14699457679
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Congestive Heart Failure Market Size in the 7MM was ~USD 6 Billion in 2022 | DelveInsight here
News-ID: 3553840 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Heart
Heart Healthy Foods and Supplements vs Heart Conditions
Heart conditions remain a major health concern worldwide, but the good news is that specific heart healthy foods and supplements can significantly improve cardiovascular health.
Scientific research has demonstrated that certain foods, nutrients and supplements support heart function, reduce inflammation, and lower the risk of heart disease.
Top Heart Healthy Foods
Fatty Fish - Salmon, mackerel, and sardines are rich in omega-3 fatty acids, which help lower blood pressure and reduce inflammation. A…
Centrifugal Heart Pumps Market | Abbott Laboratories, Abiomed, Berlin Heart, Car …
The global centrifugal heart pumps market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the centrifugal heart pumps market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
Heart disease and Heart Attacks - Kaffailham.gr
Καρδιολόγος Αθηνα - https://kaffailham.gr
When people talk about heart disease or heart attacks. The arteries that they are talking about are the arteries that actually provide blood to the heart. Remember the heart itself is a muscle. It itself needs oxygen. So you have these arteries right over here, the red tubes. Those are arteries. and then the blue ones are veins. They're taking the de-oxygenated blood away from the tissue…
Artificial Heart Implant Market May See a Big Move | Major Giants Jarvik Heart, …
The Latest survey report on Artificial Heart Implant Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Artificial Heart Implant organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Medtronic, Boston Scientific, Abbott, Terumo, B.Braun, SynCardia, BiVACOR, CARMAT, ReinHeart TAH…
HEART PUMP DEVICES Market 2020 | SWOT Analysis By Top Players Abbott Laboratorie …
A detailed study on HEART PUMP DEVICES Market formulated by Brandessence Market Research, puts together a concise analysis of the growth factors impacting the current business scenario across assorted regions. Significant information pertaining to the industry's size, share, application, and statistics are also summed in the report in order to present an ensemble prediction. In addition, this report undertakes an accurate competitive analysis illustrating the status of market majors in…
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot
Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after…
